Get started
Author

Kinga Brzdęk

Observed names: Brzdęk, Kinga, K. Brzdęk
ORCID: 0009-0009-2339-8684
Observed ORCID: 0009-0009-2339-8684
OpenAlex ID: A5098711031
Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals
2024 · Krystyna Dobrowolska, Michał Brzdęk, et al. · Expert Opinion on Pharmacotherapy · 24
Steatotic liver disease in patients treated for chronic hepatitis B
2025 · Jakub Janczura, Michał Brzdęk, et al. · Polskie Archiwum Medycyny Wewnętrznej · 10
PDF
Oral manifestations in patients with chronic hepatitis C
2025 · Michał Brzdęk, Joanna Gałuszka-Garnuszek, et al. · BMC Oral Health · 5
PDF
Predictors of Severe Outcomes in COVID-19: Evidence from Real-World Multicenter Retrospective Study (2020–2024)
2026 · Małgorzata Wajdowicz, Krystyna Dobrowolska, et al. · Journal of Clinical Medicine · 4
PDF
Advances in portal hypertension management: Evolution of the Baveno guidelines
2025 · Michał Brzdęk, Krystyna Dobrowolska, et al. · World Journal of Gastroenterology · 4
Prevalence of hepatitis D virus in chronic hepatitis B patients: findings from Poland
2025 · Dorota Zarębska-Michaluk, Michał Brzdęk, et al. · Advances in Medical Sciences · 3
Steatotic liver disease in patients with chronic hepatitis C
2025 · Jakub Janczura, Michał Brzdęk, et al. · World Journal of Hepatology · 2
PDF
Triple agonists of GIP, GLP-1, and glucagon - the future of obesity treatment: a review of the latest findings
2024 · Kinga Brzdęk, Michał Brzdęk · MEDICAL SCIENCE PULSE · 2
Does rheumatoid arthritis affect the course of chronic hepatitis C and outcomes of antiviral treatment?
2026 · Kinga Brzdęk, Dorota Zarębska-Michaluk, et al. · Polskie Archiwum Medycyny Wewnętrznej · 1
The impact of tirzepatide on lipid profile based on the SURMOUNT clinical trials
2024 · Kinga Brzdęk, Michał Brzdęk · Lekarz Wojskowy · 1
PDF
Cases of de novo hepatocellular carcinoma after successful direct-acting antiviral therapy in patients without cirrhosis
2026 · Dorota Zarębska-Michaluk, Robert Flisiak, et al. · Polskie Archiwum Medycyny Wewnętrznej
PDF
Risk of Liver and Non-Liver Malignancy in HCV-Infected Patients with Cirrhosis After Direct-Acting Antiviral Treatment
2026 · Dorota Zarębska-Michaluk, Krystyna Dobrowolska, et al. · Cancers
PDF
Hepatitis A virus-induced autoimmune hepatitis: A case-based review
2026 · Jakub Janczura, Michał Brzdęk, et al. · World Journal of Hepatology
WED-617-YI Hepatic and extrahepatic malignancies in hepatitis C virus-infected patients with cirrhosis treated with direct-acting antivirals in long-term observation
2026 · Krystyna Dobrowolska, Jakub Janczura, et al. · Journal of Hepatology
Extrahepatic manifestations of hepatitis C virus infection in the oral cavity
2025 · Joanna Gałuszka-Garnuszek, Michał Brzdęk, et al. · Medical Studies
PDF
Analysis of the safety profile of retatrutide based on phase I and II clinical trials
2025 · Kinga Brzdęk, Michał Brzdęk · Lekarz Wojskowy
PDF
The Impact of Tirzepatide on Body Mass in the Clinical Trials Surmount and Surpass
2024 · Kinga Brzdęk, Michał Brzdęk · The Polish Journal of Aviation Medicine Bioengineering and Psychology
PDF
The influence of micronutrients and macronutrients excess or deficiency on thyroid function
2024 · K. Brzdęk, S. Wiśniewski, et al. · The Ukrainian Biochemical Journal
PDF
Sjögren’s syndrome: history and challenges in diagnosis
2024 · Kinga Brzdęk, Szymon Wiśniewski, et al. · Problemy Pielęgniarstwa
PDF
Pendred syndrome: Advances in diagnostics and unresolved therapeutic challenges
2024 · Olga Domańska, Kinga Brzdęk, et al. · Problemy Pielęgniarstwa
PDF
Works count: 22
Citation count: 61
H-index: 4
I10-index: 2
Year
Topic
Type